Kolexia
Mervoyer Augustin Oncologie radiothérapie
Mervoyer Augustin
Oncologie radiothérapie
Institut de cancérologie de l'Ouest
Saint-Herblain, France
72 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Sarcomes Tumeurs du col de l'utérus Liposarcome Glioblastome Tumeurs du cerveau Récidive tumorale locale Tumeurs des tissus mous Métastase tumorale Papillome

Collaborateurs

Voir plus
Ducassou Anne
Ducassou Anne
Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France
Kantor Guy
Kantor Guy
Institut Bergonié, Bordeaux, France
Sargos Paul
Sargos Paul
Institut Bergonié, Bordeaux, France
Sunyach Tekieli Marie-Pierre
Sunyach Tekieli Marie-Pierre
Centre Léon-Bérard, Lyon, France

Industries

Voir plus
B3TSI
12 collaboration(s)
Dernière en 2023
A+A
2 collaboration(s)
Dernière en 2021
IQVIA
2 collaboration(s)
Dernière en 2023
AstraZeneca
2 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
HYPOSARC: Phase II Study Evaluating Pre- or Post-operative HYPOfractionated Radiation Therapy in Aged (≥ 70 Years) or "Fragile" (≥ 65 Years) Patients With Limb or Trunk Soft Tissue SARComa.
Essai Clinique (Institut Universitaire du Cancer Toulouse Oncopole)   21 mars 2024
Is oligometastatic disease an applicable and useful concept in haematologic malignancies? A narrative review of radiation therapy standards, modern techniques, and innovations.
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique   23 décembre 2023
Hypofractionated Stereotactic Re-irradiation and 
Anti-PDL1 Durvalumab Combination in Recurrent Glioblastoma: STERIMGLI Phase I Results.
The oncologist   11 septembre 2023
High dose (54 Gy) pre-operative helical tomotherapy for retroperitoneal liposarcoma: Results of a phase II multicenter study.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology   10 juillet 2023
STERIMGLI: A Phase I/II Multicenter Trial Evaluating the Association of Hypofractionated Stereotactic Radiation Therapy and the Anti-Programmed Death-ligand 1 (PD-L1) Durvalumab (Medi4736) for Patients With Recurrent Glioblastoma (STERIMGLI)
Essai Clinique (AstraZeneca)   24 mai 2023
The Sentinel Lymph Node in Treatment Planning: A Narrative Review of Lymph-Flow-Guided Radiotherapy.
Cancers   12 mai 2023
Multicentric development and evaluation of F-FDG PET/CT and MRI radiomics models to predict para-aortic lymph node involvement in locally advanced cervical cancer.
European journal of nuclear medicine and molecular imaging   09 mars 2023
High Dose (54 Gy) Pre-Operative Helical Tomotherapy for Retroperitoneal Liposarcoma
ASTRO Annual 2022 Meeting   01 novembre 2022
Final Safety and Health-Related Quality of LIfe Results of the Phase 2/3 Act.In.Sarc Study With Preoperative NBTXR3 Plus Radiation Therapy Versus Radiation Therapy in Locally Advanced Soft-Tissue Sarcoma.
International journal of radiation oncology, biology, physics   16 juillet 2022
Image-guided radiotherapy.
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique   22 décembre 2021